Medical Device & Pharmaceutical Regulatory Consulting in Singapore | GRP

Committed to your success, from Concept to Approval.

Medical Device and Pharmaceuticals Regulatory Affairs and Quality Consulting for Singapore

Singapore Regulatory Affairs

Upcoming Events

  1. Bio International Convention 2018

    June 4, 2018 - June 7, 2018
  2. Biotech Japan

    June 27, 2018 - June 28, 2018

GRP provides Regulatory, Clinical and Compliance services across the globe

North America
Latin America
Asia
European Union
Australia

Choose the Country

Learn more about how we can assist you with Regulatory, Clinical and Compliance services in your country of interest

MARKET OVERVIEW

Singapore has a reputation of being the gold standard for healthcare in the region due to its strong healthcare industry and excellent healthcare system. Overall, Singapore’s stable economy and political environment make it a good choice for investors looking to set up business in the Asian region.

Singapore Medical Device Market Size Singapore Pharmaceutical Market Size
 $530 billion   $1.3 billion
Projected Growth Rate: 8.5%  Projected Growth Rate: 9%

 

Singapore Economic Indicators
GDP (PPP): $469 billion
Per Capita GDP (PPP): $82,800
Real GDP Growth Rate: 2.2%
Population (millions): 5.5
Ethnic Diversity: 76.8% Chinese, 13.9% Malay, 7.9% Indian, 1.4% other

REGULATORY AUTHORITY

Singapore’s medical regulatory body is the Health Sciences Authority (HSA). In 2007, the HSA passed the Health Products Act, allowing them to conduct mandatory product registration and regulate the supply, distribution, manufacturing, import, and advertisement of all health products. Registered medical devices are listed on the Singapore Medical Device Register (SMDR), which is publicly available on the HSA’s website.